A PYMNTS Company

US: Pharma management co Catamaran announces acquisition of smaller rival

By  |  August 1, 2013

Pharmacy benefit management company Catamaran announced Thursday it has entered into an agreement to acquire its smaller rival Restat for $409.5 million. Catamaran, which also specializes in pharmaceutical technologies and services, described the deal as a “great opportunity” for the company, as Restat, which is one of the largest private PBM companies and also provides claim processing services, has a core business that “aligns perfectly” with Catamaran’s. Catamaran manages prescriptions for 25 million members.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full Content: Canada Newswire

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.